Lung Science Conference 2016

At the forefront of basic and translational respiratory science, this conference is an essential event for budding respiratory researchers looking to boost their career.

 

Educational aims

- To present the very best of international lung science research
- To highlight new discoveries likely to impact on the future of respiratory medicine
- To encourage debate and interaction between young postdoctoral scientists and established investigators

LSC 2024 - Development of chronic lung diseases: from life-spanning mechanisms to preventive therapy
LSC 2023 - Post-viral lung diseases - from basic immunology to clinical phenotypes and therapy
LSC 2022 - Mucosal immunology of the lung: balancing protective immunity and chronic inflammation

Personal ‘omics profiling

R. Chen (Stanford, USA)

Accompanying documents

Severe asthma

P. Sterk (Amsterdam, The Netherlands)

Slides

Accompanying documents

miR-17 and -21 in intercellular communication via exosomes in allergic airway inflammation

S. Bartel (Borstel, Germany)

Accompanying documents

Eicosanoids in asthma: multi-omics data interpretation

A. Mazein (Lyon, France)

Accompanying documents

COPD

R. Faner (Barcelona, Spain)

Replay

Slides

Accompanying documents

Single cell ‘omics analysis

Y. Xu (Cincinnati, USA)

Accompanying documents

Non-canonical WNT signaling is mediated by extracellular vesicles in pulmonary fibrosis

A. Martin (Munich, Germany)

Accompanying documents

Vitamin D stimulates macrophage efferocytosis and encourages a proresolution phenotype

D. Parekh (Birmingham, United Kingdom)

Accompanying documents

Building handprints of complex diseases: the U-BIOPRED case

B. De Meulder (Lyon, France)

Replay

Slides

Accompanying documents

RibomiR-seq reveals microRNAs fine-tune the transcriptome but profoundly alter translation in severe asthma

R. Martinez-Nunez (Southampton, United Kingdom)

Accompanying documents

The association between fine ambient particulate air pollution and lung cancer incidence in adventist health and smog -2 (AHSMOG-2) cohort study

L. Gharibvand (Loma Linda, United States of America)

Accompanying documents

An integrated approach to the exposome

V. Siroux (Grenoble, France)

Accompanying documents

Poster Session 1

A. Francisco-Garcia, A. Francisco-Garcia

Accompanying documents

New tools for epidemiological medical research in the digital age

M. Salathé (Genève, Switzerland)

Replay

Accompanying documents

Natural experiments and large databases in Respiratory, CVD and tobacco control

J. Vestbo (Manchester, United Kingdom)

Replay

Slides

Accompanying documents

Systemic and local metabolomics profiling reveals novel insights into the progression of emphysema

T. Conlon (Munich, Germany)

Accompanying documents

Alpha8 integrin deficiency alters branching morphogenesis and alveolarization during mouse lung development

T.P. Cremona (Bern, Switzerland)

Replay

Slides

Accompanying documents

Modelling the whole lung

J. Bates (Burlington, USA)

Replay

Slides

Accompanying documents

The use of microarray analysis of gene signalling to determine heterogeneity of COPD exacerbation phenotypes

K. Bolger (Dublin, Ireland)

Replay

Slides

Accompanying documents

Poster Session 2

N. Moyo, N. Moyo

Accompanying documents

Metabolomics for molecular phenotyping in respiratory disease

C. Wheelock (Stockholm, Sweden)

Accompanying documents

ILD and system medicine

O. Eickelberg (Munich, Germany)

Accompanying documents

Systems pharmacology

L. Edwards (Stevenage, United Kingdom)

Replay

Slides

Accompanying documents

Epigenome-wide mapping of histone modification landscape in human pulmonary arterial hypertension

P. Chelladurai (Bad Nauheim, Germany)

Accompanying documents

Transcriptomic profiling of Macrophages isolated from human Non-Small Cell Lung Carcinoma (NSCLC) reveals novel Macrophage subsets with distinct tumour response features

E.M. Garrido-Martin (Southampton, United Kingdom)

Accompanying documents

Peripheral blood myeloid-derived suppressor cells reflect disease status in IPF

I.E. Fernandez (Munich, Germany)

Accompanying documents

Identifying biomarkers of loss of control/exacerbations in asthma from exhaled breath

S. Anirban (Amsterdam, Netherlands)

Replay

Slides

Accompanying documents

Read more
ers-logo-channel

Main ERS website

Membership

ERS Respiratory Channel

Stay up to date

CONTACT ERS

Privacy policy

Cookies policy

Governance and transparency